Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Blood|March 17, 2010
Genome-wide homozygosity signatures and childhood acute lymphoblastic leukemia riskFay J Hosking, Elli Papaemmanuil, Eammon Sheridan, et al.Leukemia|April 10, 2024
Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemiaHayden L Bell, Helen J Blair, Samantha J Jepson Gosling, et al.Haematologica|December 9, 2008
MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cellsJose L R Brito, Brian Walker, Matthew Jenner, et al.Leukemia|March 30, 2012
Common genetic variation contributes significantly to the risk of childhood B-cell precursor acute lymphoblastic leukemiaV Enciso-Mora, F J Hosking, E Sheridan, et al.Nature Genetics|August 18, 2009
Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemiaElli Papaemmanuil, Fay J Hosking, Jayaram Vijayakrishnan, et al.International Journal of Immunogenetics|July 26, 2018
The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantationJean Norden, Kim F Pearce, Julie A E Irving, et al.Leukemia|March 1, 2019
SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gainPaul B Sinclair, Sarra Ryan, Matthew Bashton, et al.European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia-a report from the UKALL 2011 trialRosanna K Jackson, Martina Liebich, Philip Berry, et al.Blood|November 10, 2010
MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemiaFay J Hosking, Stephen Leslie, Alexander Dilthey, et al.British Journal of Haematology|August 28, 2015
Quantitative proteomic analysis reveals maturation as a mechanism underlying glucocorticoid resistance in B lineage ALL and re-sensitization by JNK inhibitionLindsay Nicholson, Caroline A Evans, Elizabeth Matheson, et al.Pageof 4